Hospitals | May 08, 2026
World Thalassemia Day: RGCIRC promotes shift from transfusion to transplant
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The license is valid for five years, effective from April 9, 2026
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
Emcure to distribute Roche's kidney transplant and anemia drugs in India
The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
If approved, imlifidase has the potential to transform the kidney transplant landscape by enabling highly sensitized patients to also have access to a potentially life-changing kidney transplant
Subscribe To Our Newsletter & Stay Updated
